Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

Share Price is delayed by 15 minutes
Get Live Data
0.19    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.02 (11.111%)
Market Cap: £8.15m
OBD Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biodyn Share Chart

Oxford Biodyn News

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares
26 Feb 2020

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

Oxford BioDynamics Demonstrates Use Of EpiSwitch In Lymphoma Detection
15 Jan 2020

Oxford BioDynamics Demonstrates Use Of EpiSwitch In Lymphoma Detection

Oxford BioDynamics Demonstrates Use Of EpiSwitch In Lymphoma Detection

Oxford BioDynamics In Collaboration To Evaluate EpiSwitch Biomarkers
23 Dec 2019

Oxford BioDynamics In Collaboration To Evaluate EpiSwitch Biomarkers

Oxford BioDynamics In Collaboration To Evaluate EpiSwitch Biomarkers

UK WINNERS & LOSERS SUMMARY: Renewi Jumps 23% As Dutch Eco Ban Lifted
20 Dec 2019

UK WINNERS & LOSERS SUMMARY: Renewi Jumps 23% As Dutch Eco Ban Lifted

UK WINNERS & LOSERS SUMMARY: Renewi Jumps 23% As Dutch Eco Ban Lifted

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares
11 Dec 2019

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

Director dealings: Oxford Biodynamics interim chairman ups stake
11 Dec 2019

Director dealings: Oxford Biodynamics interim chairman ups stake

(Sharecast News) - Oxford Biodynamics revealed on Wednesday that interim chairman Stephen Diggle had purchased 18,309 ordinary shares in the AIM-liste...

Oxford BioDynamics Annual Loss Widens On Increased Costs
10 Dec 2019

Oxford BioDynamics Annual Loss Widens On Increased Costs

Oxford BioDynamics Annual Loss Widens On Increased Costs

Study Using Oxford BioDynamics' EpiSwitch Enrols First Patient
25 Oct 2019

Study Using Oxford BioDynamics' EpiSwitch Enrols First Patient

Study Using Oxford BioDynamics' EpiSwitch Enrols First Patient